Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-κB activation and adhesion molecule expressionFinancial support: During this study WJZ was supported by a North-South Dialogue scholarship EH-project 894 from The Austrian Academic Exchange Service (öAD). This work was supported by grants from The Austrian Fund for the Promotion of Scientific Research to JW (P9479) and BRB (P8011 and P8854).
07 March 2003
Accepted after resubmission 03 July 2003
05 December 2017 (online)
The regulated expression of adhesion molecules on the surface of endothelial cells is a key process in the pathogenesis of inflammation. The saponin astragaloside IV (AS-IV), a 3-O-β-D-xylopyranosyl-6-O-β-D-glucopyranosylcycloastragenol purified from the Chinese medical herb Astragalus membranaceus(Fisch) Bge.has been shown to have anti-inflammatory effects in vivo.In this study we have investigated the effect of AS-IV on cytokine-and LPS-stimulated expression of adhesion molecules in and leukocyte adhesion to endothelial cells. We have demonstrated that AS-IV significantly reduced the adhesion promoting activity of LPS-stimulated HUVECs for polymorph-nuclear leukocytes (PMNs) and the monocytic cell line THP-1. Furthermore, by using specific cell ELISAs we could show that AS-IV decreased the LPS-induced expression of E-selectin and VCAM-1 on the surface of HUVECs in a dose and time dependent manner, whereas the expression of ICAM-1 was not affected by AS-IV. AS-IV also inhibits TNFβ-induced VCAM-1 expression. The saponin octyl-D-glucopyranoside had no effect on the LPS-induced expression of E-selectin and VCAM-1 excluding an unspecific detergent-like effect of AS-IV. Moreover, AS-IV significantly inhibited LPS- and TNFβ-induced specific mRNA levels for E-selectin and VCAM-1. Finally, we could show that AS-IV completely abolished LPS- and TNFα-induced nuclear translocation of NF-κB and NF-κB DNA binding activity in endothelial cells. We conclude that the ability of AS-IV to inhibit the NF-κB pathway might be one underlying mechanism contributing to its anti-inflammatory potential in vivo.
- 1 Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84: 2068-101.
- 2 Rothlein R, Dustin MI, Marlin SD. et al. A human intercellular adhesion molecul (ICAM-1) distinct from LFA-1. J Immunol 1986; 137: 1270-4.
- 3 Bevilacqua MP, Pober JS, Mendrick DL. et al Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Nat Acad Sci USA 1987; 84: 9238-42.
- 4 Rice GE, Munro JM, Bevilacqua MP. Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. A CD11/CD18-independent adhesion mechanism. J Exp Med 1990; 171: 1369-74.
- 5 Kukielka GL, Hawkins HK, Michael LL. et al Regulation of intercellular adhesion molecule-1 (ICAM-1) expression in ischemic and reperfused myocardium. J Clin Invest 1993; 92: 1504-16.
- 6 Griffin RL, Krzesicki RF, Fidler SF. et al Attenuation of oxidant-induced lung injury by 21-aminosteroids (lazaroids): correlation with the mRNA expression for E-selectin, P-selec-tin, ICAM-1 and VCAM-1. Environ Health Perspect 1994; 102: 193-200.
- 7 Fries JW, Williams AJ, Atkins RC. et al Expression of E-selectin and VCAM-1 in an in vivo model of endothelial activation. Am J Pathol 1993; 143: 725-37.
- 8 Montefort S, Gratziou C, Goulding D. et al Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J Clin Invest 1994; 93: 1411-21.
- 9 Gonzalez-Amaro R, Sanchez-Madrid F. Cell adhesion molecules: selectins and integrins. Crit Rev Immunol 1999; 19: 389-429.
- 10 Kubes P, Ward PA. Leukocyte recruitment and the acute inflammatory response. Brain Pathol 2000; 10: 127-35.
- 11 Zhang W, Wojta J, Binder BR. Effect of notoginsenoside R1 on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells. Arterioscl Thromb 1994; 14: 1040-6.
- 12 Zhang WJ, Wojta J, Binder BR. Notoginseno-side R1 counteracts endotoxin-induced activation of endothelial cells in vitro and endotoxin-induced lethality in mice in vivo. Arterioscl Thromb Vasc Biol 1997; 17: 465-74.
- 13 Zhang WJ, Wojta J, Binder BR. Regulation of the fibrinolytic potential of cultured human umbilical vein endothelial cells: Astragaloside IV downregulates plasminogen activator inhibitor-1 and upregulates tissue-type plasminogen activator expression. J Vasc Res 1997; 34: 273-80.
- 14 Lei ZY, Wang SR. Effect of Astragalus membranaceus on cardiovascular system. Chin J Integrated Trad West Med 1993; 13: 443-6.
- 15 Su ZZ, He YY, Chen G. Clinical and experimental study on effects of man-shen-ling oral liquid in the treatment of 100 cases of chronic nephritis. Chin J Integrated Trad West Med 1993; 13: 259-60.
- 16 Zhou QJ. Chinese medicinal herbs in the treatment of viral hepatitis. In: Advances in Chi-nese Medicinal Materials Research. Chang HM, Yeung HW, Tso WW, Koo A, eds., World Scientific. Singapore 1985; 215
- 17 Zhang BZ, Ding F, Tan LW. Clinical and experimental study on Yi-gan-ning granule in treating chronic hepatitis B. Chin J Integrated Trad West Med 1993; 13: 597-9.
- 18 Rui T, Yang Y, Zhao T. et al Effect of Astragalus membranaceus on electrophysiological activities of acute experimental Coxsackie B-3 viral myocarditis in mice. Chin Med Sci J 1993; 8: 203-6.
- 19 Hong CY, Lo YC, Tan FC. et al Astragalus membranaceus and Polygonum multiflorum protect rat heart mitochondria against lipid peroxidation. Am J Chin Med 1994; 22: 63-70.
- 20 Wojta J, Holzer M, Hufnagl P. et al Hyper-thermia stimulates plasminogen activator inhibitor type 1 expression in human umbilical vein endothelial cells in vitro. Amer J Pathol 1991; 139: 911-9.
- 21 Hoover RL, Folger R, Haering WA. et al Adhesion of leukocytes to endothelium: roles of divalent cations, surface charge, chemotactic agents and substrate. J Cell Sci 1980; 45: 73-86.
- 22 Wrighton CJ, Hofer-Warbinek R, Moll T. et al Inhibition of endothelial cell activation by adenovirus-mediated expression of IκBα, an inhibitor of the transcription factor NF-κB. J Exp Med 1996; 183: 1013-22.
- 23 Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci USA 1989; 86: 2336-40.
- 24 Riedemann NC, Ward PA. Oxidized lipid protects against sepsis. Nat Med 2002; 8: 1084-5.
- 25 Bochkov VN, Kadl A, Huber J. et al Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Nature 2002; 419: 77-81.
- 26 Bianchi E, Bender JR, Biasi F. et al Through and beyond the wall: late steps in leukocyte transendothelial migration. Immunol Today 1997; 18: 586-91.
- 27 Olofsson AM, Arfors KE, Ranezani L. et al E-selectin mediates leukocyte rolling in interleukin-1-treated rabbit mesentery venules. Blood 1994; 84: 2749-58.
- 28 Alon R, Kassner PD, Carr MW. et al The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J Cell Biol 1995; 128: 1243-53.
- 29 Cybulsky I M, Iiyama K, Li H. et al A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001; 107: 1255-1262.
- 30 Gerszten RE, Lim YC, Ding HT. et al Adhesion of monocytes to vascular cell adhesion molecule-1-transduced human endothelial cells: implications for atherogenesis. Circ Res 1998; 82: 871-8.
- 31 Mercurio F, Manning AM. Multiple signals converging on NF-κB. Curr Opinion Cell Biol 1999; 11: 226-32.
- 32 Weber C, Erl W, Pietsch A. et al Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler Thromb 1994; 14: 1665-73.
- 33 Marui N, Offermann MK, Swerlick R. et al Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993; 92: 1866-74.
- 34 Faruqi RM, Poptic EJ, Faruqi TR. et al Distinct mechanisms for N-acetylcysteine inhibition of cytokine-induced E-selectin and VCAM-1 expression. Am J Physiol 1997; 273: H817-826.
- 35 Zapolska-Downar D, Zapolski-Downar A, Markiewski M. et al Selective inhibition by alpha-tocopherol of vascular cell adhesion molecule-1 expression in human vascular endothelial cells. Biochem Biophys Res Commun 2000; 274: 609-15.
- 36 Pober JS, Slowik MR, De Luca LG. et al Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. J Immunol 1993; 150: 5114-23.
- 37 Yan W, Zhao K, Jiang Y. et al Role of p38 MAPK in ICAM-1 expression of vascular endothelial cells induced by lipopolysaccha-ride. Shock 2002; 17: 433-8.
- 38 Wang N, Verna L, Liao Hl. et al Adenovirus-mediated overexpression of dominant-negative mutant of c-Jun prevents intercellular adhesion molecule-1 induction by LDL: a critical role for activator protein-1 in endothelial activation. Arterioscler Thromb Vasc Biol 2001; 21: 1414-20.
- 39 Fan H, Sun B, Gu Q. et al Oxygen radicals trigger activation of NF-kappaB and AP-1 and upregulation of ICAM-1 in reperfused canine heart. Am J Physiol 2002; 282: H1778-1786.
- 40 Berendji-Grun D, Kolb-Bachofen V, Kroncke KD. Nitric oxide inhibits endothelial IL-1β-induced ICAM-1 gene expression at the transcriptional level decreasing Sp1 and AP-1 activity. Mol Med 2001; 7: 748-54.